Meeting
2017 ASCO Quality Care Symposium
The use of real-world data to examine comparative effectiveness research (CER) and treatment patterns in HER2-negative and triple-negative metastatic breast cancer (MBC): A systematic literature review.
Authors
Monika Parisi
Celgene Corporation, Summit, NJ
Monika Parisi, Corey Pelletier, Dasha Cherepanov, Michael S Broder, Nadia Noormohamed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Safety and Science of Quality
Track
Patient Safety,Science of Quality
Sub Track
Quality Measurement
Citation
J Clin Oncol 35, 2017 (suppl 8S; abstract 210)
DOI
10.1200/JCO.2017.35.8_suppl.210
Abstract #
210
Poster Bd #
D15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.
First Author: Javier Puente
Poster
2022 ASCO Annual Meeting
Treatment patterns and their impact on the outcome of patients with HR+/HER2+ metastatic breast cancer in a large real-world cohort.
First Author: Marcela Carausu
Poster
2022 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns, survival outcomes, and health care resource utilization among individuals with nonmuscle-invasive bladder cancer in Canada.
First Author: Tamer N. Jarada
Poster
2019 ASCO Annual Meeting
Real-world treatment patterns and outcomes in ER+/PR+/HER2+ metastatic breast cancer (MBC) patients: A National Cancer Database analysis.
First Author: Abby Statler